Close Menu
Products
DetectX® Assay Kits
AbX® Antibodies
Components & Ancillary Reagents
Inhibitors & Activators
Detection Systems
Products by Research Areas
Current Promotions
Resources
Recent Publications
Protocols
Videos
Assay and Kit Resources
Links
FAQs
Publications
Ordering
Ordering
Distributors
About Us
Employee Ownership
Meet the Team
Community Support
Our Board and Founders
Our Why
News
Careers
Contact
Contact Us
Technical Support
ISWE Partnership
Login
Cart
0
Added to Cart
Product SKU:
Checkout
View Cart
Skip to content
About Us
Community Support
Employer Ownership
Careers
Meet the Team
Our Board and Founders
Our Why
News
Contact
Customer Service
Technical Support
News
ISWE Partnership
Products
DetectX® Assay Kits
AbX® Antibodies
Detection Systems
Components & Ancillary Reagents
Inhibitors & Activators
Research Areas
Current Promotions
Resources
Recent Publications
FAQs
Protocols
Videos
Assay and Kit Resources
Links
Ordering
Ordering
Distributors
My account
Publications
Search
Search for:
Search
Login
Cart
0
Added to Cart
Product SKU:
Checkout
View Cart
Toggle navigation
Menu
The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis
Publish Date
06/06/2024
Category
Keywords
Back to All Posts
Back to Top
Login
Sign Up
Remember me
Subscribe to our newsletter
I accept the
Terms of Service and Privacy Policy
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
